RCSI Bahrain continues to meet Global Healthcare Educational Standards and support the development of national healthcare programmes in the Gulf Countries

Bahrain, Manama, May 10, 2022 (GLOBE NEWSWIRE) — In line with the global standards of quality medical education, the Royal College of Surgeons in Ireland – Medical University of Bahrain (RCSI Bahrain) received re-accreditation from the Medical Council of Ireland (IMC) for its undergraduate medicine programme in 2021, and revalidation from the Bahrain Education & Training Quality Authority (BQA) for its undergraduate nursing and MSc in nursing programmes in 2022. The undergraduate medicine programme has been accredited by the IMC since 2014 and the RCSI Bahrain School of Medicine is included in the World Directory of Medical Schools and listed on the International Association of Universities’ “List of Universities of the World” by the UNESCO.

To perform the re-accreditation process, the IMC visiting team chaired by the Medical Council Member, Professor Mary O’Sullivan, Dean of the University of Limerick, Ireland, and comprising of Council and external members, met with the RCSI Bahrain Executive Management Team, School of Medicine staff, the University’s Student Council, students from all year groups and RCSI Bahrain interns. This being to carry out the undergraduate medicine programme accreditation in alignment with the World Federation of Medical Education’s (WFME) ‘Global Standards for Quality improvement in Medical Education’ framework. The IMC issued a five-year renewal of the accreditation of the undergraduate medicine programme, which is valid until November 2026.

The BQA’s review panel led by Professor Erika Sirsch, acting Dean of the nursing science faculty at the Philosophical-Theological University of Vallendar, Germany, comprised of three regional and international healthcare professionals, in addition to the BQA members. The review involved meetings with the RCSI Bahrain Executive Management Team, staff from both the School of Nursing and Midwifery and the School of Postgraduate Studies and Research, staff across the University’s support units, as well as students and alumni. RCSI Bahrain received the decision of Full Confidence from the BQA and it continues to maintain its valid status as placed on National Qualifications Framework of Bahrain (NQF) for its Undergraduate Nursing and MSc in Nursing programmes.

Both visits from the IMC and BQA involved several meetings with RCSI Bahrain training leads and Clinical Lecturers and Tutors, programme Advisory Boards and employers from the Ministry of Health and the University’s partner hospitals including King Hamad University Hospital, Bahrain Defence Force Hospital – Royal Medical Services, Salmaniya Medical Complex, American Mission Hospital, multiple health centres across Bahrain and Cleveland Clinic in Abu Dhabi, UAE.

President of RCSI Bahrain, Professor Sameer Otoom commented, “With our accreditation standards and a world-renowned curriculum, RCSI Bahrain graduates attain a level of knowledge and clinical experience to compete for rewarding career opportunities worldwide, as well as supporting the development of national healthcare programmes in the Gulf Countries”.

About RCSI Bahrain

RCSI Bahrain is a constituent university of RCSI, which was established in Dublin, Ireland, in 1784. RCSI Bahrain, an independent private university, opened its doors to a cohort of 28 medical students in 2004. It is a not-for-profit health sciences institution focused on education and research to drive positive change in all areas of human health worldwide. Today, the purpose-built campus is home to a student body of more than 1,300 across Schools of Medicine; Nursing and Midwifery and Postgraduate Studies and Research.

For more information, please visit www.rcsi.com/bahrain

RCSI Bahrain Instagram

RCSI Bahrain Facebook

RCSI Bahrain LinkedIn

Attachments

Doaa Magdy
Royal College of Surgeons in Ireland - Medical University of Bahrain (RCSI Bahrain)
+97316660194  /  +973 39929700
dmagdy@rcsi-mub.com

Reuters Partners with The Globe and Mail’s Sophi.io Automation Platform

TORONTO, May 10, 2022 (GLOBE NEWSWIRE) — Sophi.io, an AI-powered automation, optimization and prediction platform developed by The Globe and Mail, is now working with Reuters – the news and media division of Thomson Reuters – as it continues to invest in the latest AI solutions for its newsroom. Sophi is helping to automate content curation on select sections on Reuters.com, which was relaunched in April 2021.

Sophi Site Automation is an AI system that autonomously curates digital content to find and promote an organization’s most engaging content. Sophi looks at all content as it’s published, and all traffic, to find the hidden gems that an organization’s customers value the most.

In order to automate content curation, Sophi’s algorithm has been learning from Reuters editors. The newsroom has been able to work with some of the latest AI solutions, which has resulted in giving time back to editors to focus on finding the next story and creating the journalism that makes Reuters such a trusted brand.

Josh London, Head of Reuters Professional and Chief Marketing Officer of Reuters, said: “Sophi’s cutting-edge AI platform is one of the next steps in the evolution of our digital properties. Sophi will help us further our mission of bringing AI-based technology and tools to more corners of the workforce, whilst helping to bring our readers the stories they both want and need to know.”

Michael Young, Chief Technology Officer for Reuters, said: “Our partnership with Sophi.io is another example of how a newsroom like ours can successfully deploy some of the latest AI solutions for effective content discovery. Our team worked closely with the Sophi team to ensure our Sophi Score reflected our business goals and we are pleased with the resulting site automation.”

Mike O’Neill, Co-Founder and CEO of Sophi.io, added “We are delighted to have Reuters as a customer. They put their trust in Sophi and we are excited to automate curation across all of their article pages to start and expand the relationship to include more solutions down the road.”

“It’s wonderful to work with Reuters in this capacity,” said Phillip Crawley, Publisher and CEO of The Globe and Mail. “They have a strong mission and Sophi.io is helping them continue to demonstrate how editorial integrity can be supported by AI.”

About Reuters
Reuters is the world’s leading provider of trusted news, insight and analysis, reaching billions of people worldwide every day. Founded in 1851, it brings together world-class journalism, industry expertise and cutting-edge technology with unparalleled speed, reliability and accuracy to enable people to make better decisions. Reuters is committed to the Trust Principles of independence, integrity and freedom from bias, and is the essential source of business, financial and world news delivered to financial professionals exclusively via Refinitiv services, and to the world’s media organizations, industry events and directly to consumers.

About Sophi.io
Sophi.io (https://www.sophi.io) was developed by The Globe and Mail to help content publishers make important strategic and tactical decisions. It is a suite of AI and ML-powered automation, optimization and prediction solutions that include Sophi Site Automation, Sophi for Paywalls and Sophi for First Party Data. Sophi also powers one-click automated laydown of template-free print publishing. Sophi is designed to improve the metrics that matter most to your business, such as subscriber retention and acquisition, engagement, recency, frequency and volume.

Contact us
Kayley Rogers
Communications Manager
Reuters
Kayley.rogers@thomsonreuters.com

Jamie Rubenovitch
Head of Marketing, Sophi.io
The Globe and Mail        
jrubenovitch@globeandmail.com
416-585-3355

‫2022 چائنا انٹرنیشنل بگ ڈیٹا انڈسٹری ایکسپو 26 مئی کو آن لائن منعقد ہوگی

گوئیانگ، چین، 10 مئی 2022 /ژنہوا ایشیانیٹ/–  7 مئی 2022 کو چائنا انٹرنیشنل بگ ڈیٹا انڈسٹری ایکسپو (جسے بعد میں “ڈیجیٹل ایکسپو” کہا جاتا ہے) کی پریس کانفرنس گوئیانگ میں منعقد ہوئی، چائنا انٹرنیشنل بگ ڈیٹا انڈسٹری ایکسپو آرگنائزنگ کمیٹی کے مطابق 2022 ڈیجیٹل ایکسپو ایک دن کے لئے کلاؤڈ کانفرنس کی شکل اختیار کرے گی جو 26 مئی 2022 کو آن لائن منعقد ہوگی۔

2022 چائنا انٹرنیشنل بگ ڈیٹا انڈسٹری ایکسپو

ایکسپو بگ ڈیٹا تھیم کے ساتھ دنیا کی پہلی قومی ایکسپو ہے جو مسلسل سات سیشنز کے لئے منعقد کی گئی ہے۔ یہ تازہ ترین کامیابیوں کو ظاہر کرنے اور صنعت کی ترقی کی قیادت کرنے اور ترقیاتی خیالات کے تبادلے اور تعاون کے مواقع پیدا کرنے کے لئے ایک عالمی معیار کا پلیٹ فارم بنانے کے لیے ایک بین الاقوامی تقریب بن گئی ہے۔

ایکسپو “ڈیجیٹل نئی مشین پر قبضہ کریں، ڈیجیٹل ویلیو سے لطف اندوز ہوں” سالانہ موضوع پر قائم رہیں گی، “عالمی نقطہ نظر، قومی اونچائی، صنعتی نقطہ نظر، انٹرپرائز پوزیشن” کے تصور پر عمل پیرا رہیں گے اور “اعلیٰ درجے، تخصیص، بین الاقوامیت، صنعتکاری، پائیدار” کے مقصد پر عمل پیرا رہیں گے، “سادہ بچت، عملی اور موثر” کے اصول کو اجاگر کریں گے، ڈیجیٹل معیشت اور حقیقی معیشت کے انضمام کو تیز کریں گے، روایتی صنعتوں کی تبدیلی اور اپ گریڈنگ کو فعال بنائیں گے اور آن لائن سرگرمیاں منعقد کریں گے جن میں “افتتاحی تقریب”، “ڈیجیٹل ویلی فورم”، “ڈیجیٹل ایکسپو ریلیز”شامل ہیں۔

اس عرصے کے دوران زندگی کے ہر شعبے سے تعلق رکھنے والے افراد کو آن لائن مدعو کیا جائے گا کہ وہ “کمپیوٹنگ”، “ڈیٹا سیکورٹی” اور “میٹا ورس” جیسے جدید ترین موضوعات پر 8 فورمز منعقد کریں اور ایکسپو کے دن سائنسی اور تکنیکی کامیابیوں کے ایوارڈز اور انٹرپرائز کامیابیوں کی قیادت کرنے والے عالمی بڑے ڈیٹا جاری کیے جائیں گے۔

حالیہ برسوں میں ڈیجیٹل ایکسپو بتدریج بڑے ڈیٹا اور بین الاقوامی اور پیشہ ورانہ پلیٹ فارم کی ترقی کا مرکز بن گیا ہے جبکہ صوبہ گوئژو میں بڑے ڈیٹا کی ترقی کے مواقع پیدا کرنے اور وسائل اکٹھا کرنے کا بھی موقع پیدا کر رہا ہے۔ چین میں ڈیجیٹل معیشت نے مسلسل چھ سالوں سے پہلی ترقی کی ہے۔ گوئیانگ گیان ان علاقوں میں سے ایک بن گیا ہے جہاں دنیا میں سب سے زیادہ بڑے ڈیٹا سینٹرز ہیں۔ سافٹ سروس انڈسٹری کی آمدنی کی شرح نمو چین میں سرفہرست ہے، سرکاری محکموں کے نیٹ ورک اور ڈیٹا کو پورا کرنے اور متحدہ ڈیجیٹل حکومت کے پلیٹ فارم اور چین میں بڑے ڈیٹا ایکسچینج کی تعمیر میں پہلا، قومی مربوط کمپیوٹنگ نیٹ ورک قومی مرکز نوڈ وغیرہ کی تعمیر کی منظوری دی گئی۔ گوئژو میں بڑا ڈیٹا ایک “خوبصورت کاروباری کارڈ” بن گیا ہے۔

مزید معلومات کے لئے، براہ کرم ملاحظہ کریں: https://www.bigdata-expo.cn

ماخذ: چائنا انٹرنیشنل بگ ڈیٹا انڈسٹری ایکسپو آرگنائزنگ کمیٹی

تصویر منسلک کرنے کے لنکس:

لنک:    http://asianetnews.net/view-attachment?attach-id=420723

 

 

Taconic Biosciences Appoints Nomura Siam as Distributor in India for All Taconic Animal Models

Improves Access to Critical Rodent Models for Researchers in India

RENSSELAER, N.Y., May 10, 2022 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, has appointed Nomura Siam International Co., Ltd (NSI), an established distributor of laboratory animals and related products, as its preferred distributor in India.

India makes a significant contribution to global pharmaceutical and vaccine production, and its pharmaceutical and biotechnology research and development is expected to grow over the next decade. To support this growth, scientists in India need advanced mouse and rat models for pharmacology studies and toxicology and drug safety assessment. Research across all therapeutic areas requires genetically engineered models (GEMs). Additionally, mice with humanized immune systems are critical for immuno-oncology and other applications.

Taconic’s portfolio comprises nearly 4,700 mouse and rat models, including widely used standard strains, immunodeficient models, and exclusive GEMs. Taconic is also a global leader in humanized immune system mouse generation. Taconic’s industry-leading quality systems, genetic integrity, and globally harmonized animal health standards promote research reproducibility while its flexible approach to licensing reduces barriers to accessing valuable GEMs.

Based in Thailand, NSI is known for its focus on quality and customer service. The company’s new agreement with Taconic significantly increases preclinical researchers’ access to GEMs in India and allows NSI to offer this market a full spectrum of solutions.

“To date, rodent model selection and availability has been somewhat limited in India. We believe this partnership will provide India’s growing pharmaceutical industry access to the most sophisticated and high-quality animal models available globally,” said Dr. Michael Seiler, vice president of commercial products at Taconic. “We truly believe this partnership will support Taconic’s desire to accelerate new life-saving therapeutics for the global community.”

“Taconic’s portfolio of sophisticated mouse models fills a major gap in the Indian market,” said Taiichiro Kamiya, president of NSI. “By our frequent information sharing, and the improvement of logistic process, we will provide faster and easier access to GEMs for Indian users.”

To learn more about Taconic’s full line of animal model solutions, please call 1-888-TACONIC (888-822-6642) in the US, +45 70 23 04 05 in Europe, or email info@taconic.com.

About Taconic Biosciences, Inc.

Taconic Biosciences is a fully licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic provides the best animal solutions so that customers can acquire, custom-generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, microbiome, immuno-oncology mouse models, and integrated model design and breeding services, Taconic operates service laboratories and breeding facilities in the US and Europe, maintains distributor relationships in Asia, and has global shipping capabilities to provide animal models almost anywhere in the world.

About Nomura Siam International Co. Ltd. (NSI)

Nomura Siam International Co. Ltd., based in Bangkok, Thailand, was jointly established in 2012 by CLEA Japan, Inc. and Nomura Jimusho, Inc. as a comprehensive provider for the laboratory animal field. As a one-stop service supplier, NSI not only sells laboratory animals but also handles a wide range of related products, including equipment for breeding, conducting experiments, and environmental enrichment, as well as consulting services for preclinical research and laboratory animal facility design.

Media Contact:

Aidan Bouchelle
Associate Director, Marketing Operations
518-949-7598
Aidan.Bouchelle@taconic.com

Eurora Solutions is participating in the World Mail & Express EMEA conference

Eurora management team: (from left) Marko Lastik (founder), Anneli Aljas (CFO), Egon Veermäe (COO).

Eurora Solutions raises $40M in Series A to tackle e-commerce shipping delays caused by EU regulation changes.

TALLINN, Estonia, May 10, 2022 (GLOBE NEWSWIRE) — Eurora Solutions, an Artificial Intelligence/Machine Learning-backed (AI/ML) cross-border e-commerce compliance platform, is pleased to announce that its management team will take part in the World Mail & Express EMEA conference between 10-12 May in Dubai, United Arab Emirates.

The Company’s attendance follows Eurora’s oversubscribed $40m Series A round, announced last month. Eurora plans to use the funds for global expansion, including in the Middle East, where rapid and high growth in the sector is expected – between 2016 and 2020 alone, the size of the e-commerce industry quadrupled in the region.

On Wednesday 11th of May, Eurora’s COO, Egon Veermäe, will present the company introduction titled “Reshaping Cross-Border Trade with AI-Based Solutions,” which will give an overview of Eurora’s AI/ML-based e-commerce compliance platform that automates tax, compliance and customs services and can be used by online sellers, marketplaces, logistics and postal companies, and tax and customs authorities.

Eurora’s COO, Egon Veermäe, said: “I look forward to introducing Eurora at this leading e-commerce conference. Our platform is already used by hundreds of clients worldwide helping with tax and customs procedures. We view the Middle East as a priority market, and I’m confident that we’ll be able to find new potential partners that could benefit from Eurora’s platform and add value to our existing customers.”

Eurora’s platform automatically processes 5,000 requests per second with up to 96% accuracy, the highest level of accuracy, speed, and automation available on the market. It operates at a fraction of the time and price of hybrid or manual code allocation solutions commonly used today. It assigns e-commerce products an appropriate HS code, calculates the applicable VAT and duty amounts, and automatically creates electronic declarations for duties and taxes via simple API integration.

Interested parties can learn more about Eurora’s proprietary e-commerce compliance platform at Eurora’s conference booth no 15 located at the InterContinental Dubai Festival City.

The following representatives of Eurora will be present at the WMX EMEA and available for meetings:

For more information:   

Name Position
Anneli Aljas CFO pr@eurora.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/155b829d-c159-43eb-823a-8bb9d8e080e9

Hitachi Energy launches game-changing power semiconductor module globally for all types of electric vehicles

High-performance power electronics take e-mobility to the next level and advance a more sustainable energy future for all

Zurich, Switzerland, May 10, 2022 (GLOBE NEWSWIRE) — Hitachi Energy, the global technology and market leader in power grids, today announced it will launch globally RoadPak, its pioneering power semiconductor module for electric vehicles at PCIM Europe, the world’s leading power electronics trade fair in Nuremberg, Germany, May 10-12.

RoadPak sets a new benchmark in electric vehicle performance. This compact module uses state-of-the-art silicon carbide (SiC) technology to achieve exceptional levels of power density for faster charging, reliability over the vehicle’s lifetime, and the lowest possible power losses for the longest possible driving range.

“RoadPak is the result of more than 100 years of Hitachi Energy innovation and market leadership in power electronics,” said Niklas Persson, Managing Director of Hitachi Energy’s Grid Integration business. “Along with our Grid-eMotion™ Flash and Fleet EV charging systems, it builds on our commitment to take e-mobility to the next level and advance a more sustainable energy future for all.”

Tested by many EV manufacturers and with two seasons of flawless performance with the Mahindra Racing Formula E team, RoadPak is available in both the 750 volt and 1,200 volt ranges. This makes it ideal for all types of electric vehicle – regular and luxury cars, commercial vehicles, buses, agricultural EVs, heavy-duty trucks and high-performance racing cars.

“We have had the privilege of piloting this advanced power module on our Mahindra M7Electro and M8Electro racing cars over the last two years, which has proven to significantly increase performance and reliability,” said Dilbagh Gill, CEO and Team Principal of Mahindra Racing. “This high technology improvement allows us to develop next-generation state-of-the-art green automotive solutions and improve driving experience.”

Power semiconductors are a critical component in electric vehicles. They are the heart of the inverter, which converts DC power from the vehicle’s battery into the AC power that drives the motor. Reliability is key. RoadPak semiconductors are designed to operate faultlessly for more than four million start-stop cycles over the vehicle’s lifetime.

The EV market is growing exponentially. Global sales of electric cars grew 40 percent in 2020 and almost doubled in 2021.1 In addition, all major car manufacturers have committed to phase out their petrol and diesel vehicles by 2030 or earlier.

Hitachi Energy has two separate manufacturing sources supporting security of supply worldwide for its SiC-based power semiconductor products, including RoadPak. The company makes its own SiC chips at its semiconductor factory in Switzerland and is supported by an independent SiC chip manufacturer in the United States, thereby securing supply in terms of both volumes and geographic availability.

Hitachi Energy’s advanced semiconductor technology is a key component in its grid integration solutions that enable vast amounts of renewable energy to flow reliably through power grids and between nations. They are also key to the traction converter systems that drive high-speed electric trains and metros, and the electric vehicles that are making road transportation clean and sustainable.

Notes to the Editor:

1. According to the International Energy Agency and World Economic Forum respectively: https://www.iea.org/news/global-electric-car-sales-set-for-further-strong-growth-after-40-rise-in-2020 and https://www.weforum.org/agenda/2022/02/electric-cars-sales-evs/.

About Hitachi Energy Ltd.

Hitachi Energy is a global technology leader that is advancing a sustainable energy future for all. We serve customers in the utility, industry and infrastructure sectors with innovative solutions and services across the value chain. Together with customers and partners, we pioneer technologies and enable the digital transformation required to accelerate the energy transition towards a carbon-neutral future. We are advancing the world’s energy system to become more sustainable, flexible and secure whilst balancing social, environmental and economic value. Hitachi Energy has a proven track record and unparalleled installed base in more than 140 countries. Headquartered in Switzerland, we employ around 38,000 people in 90 countries and generate business volumes of approximately $10 billion USD.

About Hitachi, Ltd.

Hitachi drives Social Innovation Business, creating a sustainable society with data and technology. We will solve customers’ and society’s challenges with Lumada solutions leveraging IT, OT (Operational Technology) and products, under the business structure of Digital Systems & Services, Green Energy & Mobility, Connective Industries and Automotive Systems. Driven by green, digital, and innovation, we aim for growth through collaboration with our customers. The company’s consolidated revenues for fiscal year 2021 (ended March 31, 2022) totaled 10,264.6 billions of yen (84,136 millions of U.S. dollars), with 853 consolidated subsidiaries and approximately 370,000 employees worldwide. For more information on Hitachi, please visit the company’s website at https://www.hitachi.com.

Attachments

Rebecca Bleasdale
Hitachi Energy Ltd.
+41 78643 2613
rebecca.bleasdale@hitachienergy.com

2022 China International Big Data Industry Expo will be held online on May 26

GUIYANG, China, May 10, 2022 /Xinhua-AsiaNet/– On May 7, 2022 China International Big Data Industry Expo (hereinafter referred to as “Digital Expo”) press conference was held in Guiyang, announcing that the 2022 Digital Expo will take the form of cloud conference for one day, which will be held online on May 26,2022, according to China International Big Data Industry Expo Organizing Committee.

2022 China International Big Data Industry Expo

The Expo is the world’s first national expo with big data theme, which has been held for seven consecutive sessions. It has become an international event to show the latest achievements and lead the development of the industry and a world-class platform for exchanging development ideas and creating cooperation opportunities.

The expo will stick to “seize digital new machine, enjoy digital value” annual theme, continue to adhere to the concept of “global vision, national height, industry perspective, enterprise position” and the goal of “high-end, specialization, internationalization, industrialization, sustainable”, highlight the principle of “simple saving, pragmatic and efficient”, accelerate the integration of the digital economy and the real economy, enable the transformation and upgrading of traditional industries, and will hold online activities including “opening ceremony”, “Digital Valley Forum”, “Digital Expo release”.

During this period, people from all walks of life will be invited online to hold 8 forums on cutting-edge topics such as “Computing”, “Data security” and “metaverse”, and global big data leading scientific and technological achievements awards and enterprise achievements will be released on the day of the Expo.

In recent years, the Digital Expo has gradually become a development vane of big data and an international and professional platform, while also creating opportunities and gathering resources for the development of big data in Guizhou Province. The digital economy has grown first in China for six consecutive years. Guiyang Guian has become one of the regions with the largest number of super-large data centers in the world. Soft service industry revenue growth rate ranks among the top in China, the first in realizing the network and data of government departments and in building the unified digital government platform and the big data exchange in China, approved to build a national integrated computing network national hub node, etc. Big data has become a “beautiful business card” in Guizhou.

For more information, please visit: https://www.bigdata-expo.cn/

Source: China International Big Data Industry Expo Organizing Committee

Image Attachments Links:
Link: http://asianetnews.net/view-attachment?attach-id=420723

LeddarTech Releases Its LeddarSteer Automotive-Grade, Solid-State Digital Beam Steering Technology for LiDAR Sensor Developers

LeddarSteer DBS

LeddarSteer DBS by LeddarTech

QUEBEC, May 10, 2022 (GLOBE NEWSWIRE) — LeddarTech®, a global leader in providing the most flexible, robust and accurate ADAS and AD sensing technology, is pleased to announce the official release of LeddarSteer™, a digital beam steering solution designed for LiDAR smart sensor developers and Tier 1-2 automotive suppliers.

Digital beam steering refers to changing the direction of laser pulses in a LiDAR. Using a stack of alternating liquid crystal cells and polarization gratings enables to steer light at different angles at a specific wavelength in order to augment a LiDAR field of view while maximizing its performance, allowing digital beam steering for LiDAR to be achieved.

LeddarSteer digital beam steering offers a myriad of benefits to LiDAR smart sensor developers and Tier 1 and 2 customers, including:

  • Software-controlled on-the-fly adjustment
    • Frame-by-frame adjustment
    • Preset or customized configuration
    • Easy setup and interface
    • Voltage-controlled steering
  • Multiple LiDAR applications
    • Compatible with a wide range of LiDAR architectures
    • Enables one LiDAR to address multiple use cases
    • Field of view adjustable for various actions, including turns, exits, lane changes and slopes
    • Same LiDAR for highway and city driving
    • Reduces the number of sensors, generating cost savings
  • Automotive-grade solid-state technology, resulting in a significantly higher MTBF (mean time between failures)

LeddarSteer can be seamlessly integrated into an existing LiDAR to expand the field of view or integrated into new LiDAR development. The solution provides an enhanced signal-to-noise ratio by concentrating laser power on a small region of interest while reducing the size, cost and complexity of LiDAR components whilst maintaining or increasing the pixel count and resolution.

“For well over a decade, LeddarTech has been a leader in developing sensing solutions that enable our customers to deliver high-performance ADAS and AD sensors,” stated Mr. Charles Boulanger, CEO of LeddarTech. “LeddarSteer is the only digital beam steering smart component designed for mass production with the flexibility, reliability, cost, size and performance required by the most demanding 3D sensing applications and supported by standard automotive manufacturing process,” concluded Mr. Boulanger.

About LeddarTech

Founded in 2007, LeddarTech is a comprehensive end-to-end environmental sensing company that enables customers to solve critical sensing, fusion and perception challenges across the entire value chain. LeddarTech provides cost-effective perception solutions scalable from Level 2 ADAS to Level 5 full autonomy with LeddarVision™, a raw-data sensor fusion and perception platform that generates a comprehensive 3D environmental model from a variety of sensor types and configurations. LeddarTech also supports LiDAR manufacturers and Tier 1-2 automotive suppliers with key technology building blocks such as LeddarSteer™ digital beam steering and the LeddarEngine™, which is built on LeddarTech’s Leddar™ technology employing patented signal acquisition and processing techniques to generate a richer and cleaner return signal at a lower cost. The LeddarEngine comprises a highly integrated, scalable LiDAR SoC and software combination that enables LiDAR developers and Tier 1-2 automotive suppliers to design their own LiDAR solutions. The company is responsible for several innovations in cutting-edge automotive and mobility remote-sensing applications, with over 120 patents granted or applied for, enhancing ADAS and autonomous driving capabilities.

Additional information about LeddarTech is accessible at www.leddartech.com and on LinkedIn, Twitter, Facebook and YouTube.

Contact:
Daniel Aitken, Vice-President, Global Marketing, Communications and Investor Relations, LeddarTech Inc.
Tel.: + 1-418-653-9000 ext. 232 daniel.aitken@leddartech.com

Investor relations contact: InvestorRelations@leddartech.com
https://investors.leddartech.com/

Leddar, LeddarTech, LeddarSteer, LeddarEngine, LeddarVision, LeddarSP, LeddarCore, LeddarEcho, VAYADrive, VayaVision, XLRator and related logos are trademarks or registered trademarks of LeddarTech Inc. and its subsidiaries. All other brands, product names and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/75f154a6-27b8-4546-8614-00d3885feef0

A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/95010106-6e76-4996-ac0a-3c68c7c09d3d


Copyright © 2022 GlobeNewswire, Inc.

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Lucid Group, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – LCID

NEW YORK, May 09, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Lucid Group, Inc. (NASDAQ: LCID) between November 15, 2021 and February 28, 2022, inclusive (the “Class Period”), of the important May 31, 2022 lead plaintiff deadline.

SO WHAT: If you purchased Lucid securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Lucid class action, go to https://rosenlegal.com/submit-form/?case_id=4992 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 31, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose material adverse facts about the Company’s business and operations. Specifically, Defendants overstated Lucid’s production capabilities while concealing that “extraordinary supply chain and logistics challenges” were already significantly hampering the Company’s operations. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Lucid class action, go to https://rosenlegal.com/submit-form/?case_id=4992 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

ROSEN, LEADING INVESTOR COUNSEL, Encourages Cano Health, Inc. f/k/a Jaws Acquisition Corp. Investors with Losses to Secure Counsel Before Important May 17 Deadline in Securities Class Action – CANO, CANO.WS, JWS, JWS.U, JWS WS

NEW YORK, May 09, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cano Health, Inc. f/k/a Jaws Acquisition Corp. (NYSE: CANO, CANO.WS, JWS, JWS.U, JWS WS) between May 18, 2020 and February 25, 2022, inclusive (the “Class Period”), of the important May 17, 2022 lead plaintiff deadline.

SO WHAT: If you purchased Cano Health securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Cano Health class action, go to https://rosenlegal.com/submit-form/?case_id=4271 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 17, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Cano Health overstated its due diligence efforts and expertise with respect to acquiring target businesses; (2) accordingly, Cano Health performed inadequate due diligence into whether the Company, post-Business Combination, could properly account for the timing of revenue recognition as prescribed by ASC 606, particularly with respect to Medicare risk adjustments; (3) as a result, Cano Health misstated its capitated revenue, direct patient expense, accounts receivable, net of unpaid service provider costs, and accounts payable and accrued expenses; (4) accordingly, Cano Health was at an increased risk of failing to timely file one or more of its periodic financial reports; and (5) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Cano Health class action, go to https://rosenlegal.com/submit-form/?case_id=4271 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

ROSEN, LEADING INVESTOR COUNSEL, Encourages Homology Medicines, Inc. Investors with Losses to Secure Counsel Before Important May 24 Deadline in Securities Class Action – FIXX

NEW YORK, May 09, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Homology Medicines, Inc. (NASDAQ: FIXX) between June 10, 2019 and February 18, 2022, inclusive (the “Class Period”), of the important May 24, 2022 lead plaintiff deadline.

SO WHAT: If you purchased Homology securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Homology class action, go to https://rosenlegal.com/submit-form/?case_id=4851 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 24, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Homology had overstated the efficacy and risk mitigation regarding HMI-102, which is in Phase I/II pheNIX clinical trial and a gene therapy for the treatment of phenylketonuria (PKU) in adults; (2) accordingly, it was unlikely that Homology would be able to commercialize HMI-102 in its present form; and (3) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Homology class action, go to https://rosenlegal.com/submit-form/?case_id=4851 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages International Business Machines Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – IBM

NEW YORK, May 09, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of International Business Machines Corporation (NYSE: IBM) between April 4, 2017 and October 20, 2021, inclusive (the “Class Period”), of the important June 6, 2022 lead plaintiff deadline.

SO WHAT: If you purchased IBM securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the IBM class action, go to https://rosenlegal.com/submit-form/?case_id=5104 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 6, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Strategic Imperatives Revenue and growth, CAMSS (the sectors of “Cloud,” “Analytics,” “Mobile,” “Security,” and “Social”) and CAMSS Components’ revenue and growth, and the Company’s Segments’ revenue and growth were artificially inflated as a result of the wrongful reclassification of revenues from non-strategic to strategic to make those revenues eligible for treatment as Strategic Imperatives Revenue; (2) IBM’s present success and positive future growth prospects concerning its Strategic Imperative business strategy were being fueled by the wrongful reclassification of revenues from non-strategic to strategic to make those revenues eligible for treatment as Strategic Imperative Revenue; (3) as a result of the foregoing, defendants misled the market by portraying IBM’s Strategic Imperative’s financial performance and future prospects more favorable than they actually were as a result of the fraudulent scheme and/or the wrongful reclassification of revenues from non-strategic to strategic to make those revenues eligible for treatment as Strategic Imperatives; and (4) Total Revenue and IBM’s Segments’ revenue and growth were artificially inflated as a result of the fraudulent scheme and/or the wrongful reclassification of revenues from non-strategic to strategic and/or the wrongful recognition of revenue. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the IBM class action, go to https://rosenlegal.com/submit-form/?case_id=5104 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

        Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com